Sustained viral response to pegylated interferon alpha-2b and ribavirin in chronic hepatitis C refractory to prior treatment (Q50575290)

From Wikidata

Jump to navigation Jump to search

scientific article published on 27 September 2006

edit

Language	Label	Description	Also known as
English	Sustained viral response to pegylated interferon alpha-2b and ribavirin in chronic hepatitis C refractory to prior treatment	scientific article published on 27 September 2006

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17004124

retrieved

15 March 2018

reference URL

http://europepmc.org/abstract/MED/17004124

title

Sustained viral response to pegylated interferon alpha-2b and ribavirin in chronic hepatitis C refractory to prior treatment (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17004124

retrieved

15 March 2018

reference URL

http://europepmc.org/abstract/MED/17004124

main subject

ribavirin

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

pegylated interferon

1 reference

based on heuristic

inferred from title

author name string

A Mathew

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17004124

retrieved

15 March 2018

reference URL

http://europepmc.org/abstract/MED/17004124

L P Peiffer

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17004124

retrieved

15 March 2018

reference URL

http://europepmc.org/abstract/MED/17004124

K Rhoades

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17004124

retrieved

15 March 2018

reference URL

http://europepmc.org/abstract/MED/17004124

T McGarrity

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17004124

retrieved

15 March 2018

reference URL

http://europepmc.org/abstract/MED/17004124

publication date

27 September 2006

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17004124

retrieved

15 March 2018

reference URL

http://europepmc.org/abstract/MED/17004124

published in

Digestive Diseases and Sciences

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17004124

retrieved

15 March 2018

reference URL

http://europepmc.org/abstract/MED/17004124

volume

51

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17004124

retrieved

15 March 2018

reference URL

http://europepmc.org/abstract/MED/17004124

issue

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17004124

retrieved

15 March 2018

reference URL

http://europepmc.org/abstract/MED/17004124

page(s)

1956-1961

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17004124

retrieved

15 March 2018

reference URL

http://europepmc.org/abstract/MED/17004124

cites work

Long-Term Histologic Improvement and Loss of Detectable Intrahepatic HCV RNA in Patients with Chronic Hepatitis C and Sustained Response to Interferon-α Therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10620-006-9192-3

retrieved

21 January 2018

Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis C virus infection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of hepatitis C: Meta-analysis of interferon alfa-2b trials

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of fatigue and psychologic disturbances in patients with hepatitis C virus infection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peginterferon alfa-2a in patients with chronic hepatitis C.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of hepatitis C

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rising incidence of hepatocellular carcinoma in the United States

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of biochemical response to interferon alfa with histological improvement in hepatitis C: A meta-analysis of diagnostic test characteristics

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17004124

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S10620-006-9192-3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17004124

retrieved

15 March 2018

reference URL

http://europepmc.org/abstract/MED/17004124

PubMed publication ID

17004124

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17004124

retrieved

15 March 2018

reference URL

http://europepmc.org/abstract/MED/17004124

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50575290&oldid=2253334763"